BLK vs ORMP
BlackRock Inc (BLK) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the BLK and ORMP stock pages for the full models.
Not investment advice.